Current treatment for primary ciliary dyskinesia conditions

Expert Opinion on Pharmacotherapy

Volumn 5, Issue 2, 2004, Pages 369-377

  Yoo, Young ^a   Koh, Young Yull ^a  

^a Seoul National University Hospital   (South Korea)

Author keywords

adrenergic agonists; Arginine; Current treatment; Hypertonic saline; Mucociliary clearance; Primary ciliary dyskinesia; Recombinant human DNase; Uridine 5 triphosphate

Indexed keywords

AMILORIDE; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; ARGININE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; DECONGESTIVE AGENT; DORNASE ALFA; FORMOTEROL; INFLUENZA VACCINE; LONG ACTING DRUG; PNEUMOCOCCUS VACCINE; PROPRANOLOL; SALBUTAMOL; SALMETEROL; SODIUM CHLORIDE; TERBUTALINE; URIDINE TRIPHOSPHATE;

BRONCHIECTASIS; BRONCHUS SECRETION; CHROMOSOME ANALYSIS; CHRONIC SINUSITIS; CILIARY DYSKINESIA; CLINICAL EXAMINATION; CLINICAL FEATURE; COUGHING; DISEASE COURSE; DRUG EFFICACY; DRUG POTENCY; HAEMOPHILUS INFLUENZAE TYPE A; HUMAN; INCIDENCE; LUNG CLEARANCE; LUNG DISEASE; MORBIDITY; MUCOCILIARY CLEARANCE; NOSE CONGESTION; NOSE POLYP; PHYSIOTHERAPY; POSTURAL DRAINAGE; RESPIRATORY TRACT INFECTION; REVIEW; RHINORRHEA; SECRETORY OTITIS MEDIA; SIDE EFFECT; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE;

ADRENERGIC BETA-AGONISTS; ARGININE; CILIA; DEOXYRIBONUCLEASE I; HUMANS; KARTAGENER SYNDROME; SALINE SOLUTION, HYPERTONIC; URIDINE TRIPHOSPHATE;

EID: 1242341944     PISSN: 14656566     EISSN: None     Source Type: Journal    
DOI: 10.1517/14656566.5.2.369     Document Type: Review

References (60)

1. MEEKS M, BUSH A: Primary ciliary dyskinesia (PCD). Pediatr. Pulmonol. (2000) 29:307-316.
2. AFZELIUS BA, ELIASSON R, JOHNSEN O, LINDHOLMER C: Lack of dynein arms in immobile human spermatozoa. J. Cell Biol. (1975) 66:225-232.
3. ELIASSON R, MOSSBERG B, CAMNER P, AFZELIUS BA: The immotile cilia syndrome. N. Engl. J. Med. (1977) 297:1-6.
4. GREENSTONE M, RUTMAN A, DEWAR A, MACKAY I, COLE PJ: Primary ciliary dyskinesia: cytological and clinical features. Quart. J. Med. (1988) 67:405-430.
5. JONES JG: Clearance of inhaled particles from the alveoli. In: Aerosols and the Lung. Clinical and Experimental aspects. Clarke SW, Pavia D (Eds.), Butterworth, London, UK (1984): 170-196.
6. LEIGH MW: Primary ciliary dyskinesia. In: Disorders of the Respiratory Tract in Children. Chernick V, Boat TF (Eds.), WB Saunders, Philadelphia, USA (1998):819-825.
7. PERRAUDEAU M: Late presentation of Kartagener's syndrome. Br. Med. J. (1994) 308:519-521.
8. SCHIDLOW DV: Primary ciliary dyskinesia (the immotile cilia syndrome). Ann. Allergy (1994) 73:457-469.
9. RUTLAND J, DEIONGH R: Random ciliary orientation. A cause of respiratory tract disease. N. Engl. J. Med. (1990) 323:1681-1684.
10. NASTASI KJ, BLAISS MS: A seven-year-old boy with sinusitis, otitis media, and asthma. Ann. Allergy (1994) 73:15-20.
11. RUTLAND J, DEIONGH R: Ciliary dysfunction. In: Pediatric Respir. Med. Taussig LM, Landau LI (Eds.), Mosby, St. Louis, Missouri, USA (1999):1171-1178.
12. DEIONGH RU, RUTLAND J: Ciliary defects in healthy subjects, bronchiectasis and primary ciliary dyskinesia. Am. J. Respir. Crit. Care Med. (1995) 151:1559-1567.
13. STURGESS JM, CHAO J, WONG J, ASPIN N, TURNER JAP: Cilia with defective radial spokes. A cause of human respiratory disease. N. Engl. J. Med. (1979) 300:53-57.
14. GREENSTONE MA, DEWAR A, COLE PJ: Ciliary dyskinesia with normal ultrastructure. Thorax (1983) 38:875-876.
15. RAUTIAINEN M, NUUTINEN J, COLLAN Y: Short nasal cilia and impaired mucociliary function. Eur. Arch. Otorhinolaryngol. (1991) 248:271-274.
16. AFZELIUS BA: Immotile cilia syndrome: past, present and prospects for the future. Thorax (1998) 53:894-897.
17. COWAN MJ, GLADWIN MT, SHELHAMER JH: Disorders of ciliary motility. Am. J. Med. Sci. (2001) 321:3-10.
18. BUSH A, COLE P, HARIRI M et al.: Primary ciliary dyskinesia: diagnosis and standards of care. Eur. Respir. J. (1998) 12:982-988.
19. MUNRO NC, CURRIE DC, LINDSAY KS et al.: Fertility in men with primary ciliary dyskinesia presenting with respiratory infection. Thorax (1994) 49:684-687.
20. BIANCHI E, SAVASTA S, CALIGARO A et al.: HLA haplotype segregation and ultrastructural study in familial immotile cilia syndrome. Hum. Genet. (1992) 89:270-274.
21. PAN Y, MCCASKILL CD, THOMPSON K et al.: Paternal isodisomy of chromosome 7 associated with complete situs inversus and immotile cilia. Am. J. Hum genet. (1998) 62:1551-1555.
22. WITT M, WANG YF, WANG S et al.: Exclusion of chromosome 7 for Kartagener syndrome but suggestion of linkage in families with other forms of primary ciliary dyskinesia. Am. J. Hum. Genet. (1998) 64:313-318.
23. COREN ME, MEEKS M, MORRISON I, BUCHDAHL RM, BUSH A: Primary ciliary dyskinesia: age at diagnosis and symptom history. Acta Paediatr. (2002) 91:667-669.
24. EL-SAYED Y, AL-SARHANI A, AL-ESSA A-R: Otological manifestations of primary ciliary dyskinesia. Clin. Otolaryngol. (1997) 22:266-270.
25. NOONE PG, BENNETT WD, REGNIS JA et al.: Effect of aerosolised uridine-5′-triphosphate on airway clearance with cough in patients with primary ciliary dyskinesia. Am. J. Respir. Crit. Care Med. (1999) 160:144-149.
26. BROMIKER R, NEEMAN Z, BAR-OZ B, AVITAL A, BAR-ZIV J, SPRINGER C: Early diagnosis of primary ciliary dyskinesia in a newborn without situs inversus. Acta Paediatr. (2002) 91:1002-1011.
27. ROSSMAN CM, FORREST JB, RUFFIN RE, NEWHOUSE MT: Immotile cilia syndrome in persons with and without Kartagener's syndrome. Am. Rev. Respir. Dis. (1980) 121:1011-1016.
28. ROSSMAN CM, WALDES R, SAMPSON D, NEWHOUSE MT: Effect of chest physiotherapy on the removal of mucus in patients with cystic fibrosis. Am Rev Respir Dis. (1982) 126:131-135.
29. PHILLIPS GE, THOMAS S, HEATHER S, BUSH A: Airway responsiveness in primary ciliary dyskinesia: intrasubject variability and the effects of exercise and bronchodilator therapy. Eur. Respir. J. (1996) 9(Suppl. 23):36S (Abstract).
30. HASSAN JA, SAADIAH S, ROSLAN H, ZAINUDIN B: Bronchodilator response to inhaled beta-2 agonist and anticholinergic drugs in patients with bronchiectasis. Respirology (1999) 4:423-426.
31. ERNSTSON S, AFZELIUS BA, MOSSBERG B: Otologic manifestations of the immotile-cilia syndrome. Acta Otolaryngol. (1984) 97:83-92.
32. JAHRSDOERFER R, FELDMAN PS, RUBEL EW, GUERRANT JL, EGGLESTON PA, SELDEN RF: Otitis media and the immotile cilia syndrome. Laryngoscope (1979) 89:769-778.
33. PARSONS DS, GREENE BA: A treatment for primary ciliary dyskinesia: efficacy of functional endoscopic sinus surgery. Laryngoscope (1993) 103:1269-1272.
34. CHEE L, GRAHAM SM, CAROTHERS DG, BALLAS ZK: Immune dysfunction in refractory sinusitis in a tertiary care setting. Laryngoscope (2001) 111:233-235.
35. SENIOR BA, KENNEDY DW, TANABODEE J, KROGER H, HASSAB M, LANZA D: Long-term results of functional endoscopic sinus surgery. Laryngoscope (1998) 108:151-157.
36. LUND VJ, NEIJENS HJ, CLEMENT PAR, LUSK R, STAMMBERGER H: The treatment of chronic sinusitis: a controversial issue. Int. J. Pediatr. Otorhinolaryngol. (1995) 32:S21-35.
37. DRAKE-LEE AB: Medical treatment of nasal polyps. Rhinology (1994) 32:1-4.
38. SCHWARZENBERG H, ELFELDT RJ, SCHLUTER E, LINK J, HELLER M: Severe haemoptysis requiring lobectomy in an 11-year-old patient with Kartagener's syndrome. Ann. Thorac. Surg. (1997) 64:852-854.
39. HOUTMEYERS E, GOSSELINK R, GAYAN-RAMIREZ G, DECRAMER M: Regulation of mucociliary clearance in health and disease. Eur. Respir. J. (1999) 13:1177-1188.
40. SMIT HJM, SCHREURS JM, VAN DEN BOSCH JMM, WESTERMANN CJJ: Is resection of bronchiectasis beneficial in patients with primary ciliary dyskinesia? Chest (1996) 109:1541-1544.
41. PEDERSEN M, STAFANGER G: Bronchopulmonary symptoms in primary ciliary dyskinesia. A clinical study of 27 patients. Eur. J. Respir. Dis. (1983) 64:118-128.
42. PHIPPS RJ, NADEL JA, DAVIS B: Effect of alpha-adrenergic stimulation on mucus secretion and on ion transport in cat trachea in vitro. Am. Rev. Respir. Dis. (1980) 121:359-365.
43. PHIPPS RJ, WILLIAMS IP, RICHARDSON PS, PELL J, PACK RJ, WRIGHT N: Sympathomimetic drugs stimulate the output of secretory glycoproteins from human bronchi in vitro. Clin. Sci. (Lond) (1982) 63:23-28.
44. BENNETT WD: Effect of β-adrenergic agonists on mucociliary clearance. J. Allergy Clin. Immunol. (2002) 110:S291-S297.
45. DEVALIA JL, SAPSFORD RJ, RUSZNAK C, TOUMBIS MJ, DAVIES RJ: The effects of salmeterol and salbutamol on ciliary beat frequency of cultured human bronchial epithelial cells, in vitro. Pulm. Pharmacol. (1992) 5:257-263.
46. KOH YY, PARK Y, JEONG JH, KIM CK, MIN YG, CHI JG: The effect of regular salbutamol on lung function and bronchial responsiveness in patients with primary ciliary dyskinesia. Chest (2000) 117:427-433.
47. FISCHER A, HOFFMANN B: Nitric oxide synthase in neurons and nerve fibers of lower airways and in vagal sensory ganglia of man. Am. J. Respir. Ctit. Care Med. (1996) 154:209-216.
48. BARNES PJ, BELVISI MG: Nitric oxide and lung disease. Thorax (1993) 48:1034-1043.
49. GRASEMANN H, GARTIG SS, WIESSEMANN HG, TESCHLER H, KONIETZKO N, RATJEN F: Effect of L-arginine infusion on airway NO in cystic fibrosis and primary ciliary dyskinesia syndrome. Eur. Respir. J. (1999) 13:114-118.
50. LOUKIDES S, KHARITONOV S, WODEHOUSE T, COLE PJ, BARNES PJ: Effect of arginine on mucociliary function in primary ciliary dyskinesia. Lancet (1998) 352:371-372.
51. SCHUIL PJ, BERGE MT, VAN GELDER GM, GRAAMANS K, HUIZING EH: Effects of prostaglandin D2 and E2 on ciliary beat frequency of human upper respiratory cilia in vitro. Acta Otolaryngol. Stockh. (1995) 115:438-442.
52. KNOWLES MR, CLARKE LL, BOUCHER RC: Activation by extracellular nucleotides of chloride secretion in the airway epithelia of patients with cystic fibrosis. N. Engl. J. Med. (1991) 325:533-538.
53. SURI R, GRIEVE R, NORMAND C et al.: Effects of hypertonic saline, alternate day and daily rhDNase on healthcare use, costs and outcomes in children with cystic fibrosis. Thorax (2002) 57:841-846.
54. ROBINSON M, REGNIS JA, BAILEY DL, KING M, BAUTOVICH GJ, BYE PTP: Effect of hypertonic saline, amiloride, and cough on mucociliary clearance in patients with cystic fibrosis. Am. J. Respir. Crit. Care Med. (1996) 153:1503-1509.
55. BOEK WM, KELES N, GRAAMANS K, HUIZING EH: Physiologic and hypertonic saline solutions impair ciliary activity in vitro. Laryngoscope (1999) 109:396-399.
56. DESAI M, WELLER PH, SPENCER DA: Clinical benefit from nebulised human recombinant DNase in Kartagener's syndrome. Pediatr. Pulmonol. (1995) 20:307-308.
57. FAHY JV, STEIGER DJ, LIU J, BASBAUM CB, FINKBEINER WE, BOUSHEY HA: Markers of mucus secretion and DNA levels in induced sputum from asthmatic and from healthy subjects. Am. Rev. Respir. Dis. (1993) 147:1132-1137.
58. POTTER JL, SPECTOR S, MATTHEWS LW, LEMM J: Studies on pulmonary secretions. 3. The nucleic acids in whole pulmonary secretions from patients with cystic fibrosis, bronchiectasis, and laryngectomy. Am. Pev. Respir. Dis. (1969) 99:909-916.
59. FUCHS HJ, BOROWITZ DS, CHRISTIANSEN DH et al.: Effect of aerosolised recombinant human DNase on exacerbation's of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group. N. Engl. J. Med. (1994) 331:317-319.
60. BERGE MT, BRINKHORST G, KROON AA, JONGSTE JC: DNase treatment in primary ciliary dyskinesia-assessment by nocturnal pulse oximetry. Pediatr. Pulmonol. (1999) 27:59-61.